Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 5, 2009, Pages 1562-1569

  Lee, Hao Hsien ^a   Uen, Yih Huei ^a   Tian, Yu Feng ^a   Sun, Chi Shu ^a   Sheu, Ming Jen ^a   Kuo, Hsing Tao ^a   Koay, Lok Beng ^a   Lin, Ching Yih ^a   Tzeng, Ching Cherng ^a   Cheng, Chia Ju ^a   Tang, Ling Yu ^a   Tsai, Sun Lung ^a   Wang, Andrew H J ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; UVOMORULIN; WNT1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CELL SURVIVAL; DISEASE PREDISPOSITION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; WESTERN BLOTTING;

ADULT; AGED; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; WNT1 PROTEIN;

EID: 66549116951     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0039     Document Type: Article

References (52)

1. Cardigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997;11:3286-3305 (Pubitemid 28023954)
2. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810. (Pubitemid 39488658)
3. Nusse R, Varmus HE. Wnt genes. Cell 1992;69:1073-1087
4. Miller JR. The wnts. Genome Biol 2002;3:3001.1-1.15.
5. Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature 2005;434:5843-5850 (Pubitemid 40558990)
6. Staal FJT, Clevers HC. Wnt signaling and haematopoiesis: a Wnt-Wnt situation. Nat Rev Immunol 2005;5:21-30. (Pubitemid 40070328)
7. Goldring SR, Goldring MB. Eating bone or adding it: the Wnt pathway decides. Nat Med 2007;13:133-134 (Pubitemid 46245758)
8. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-1841 (Pubitemid 30639518)
9. Kusserow A, Pang K, Sturm C, et al. Unexpected complexity of the Wnt gene family in a sea anemone. Nature 2005;433:156-160
10. Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982;31:99-109.
11. Seifert JRK, Modzik M. Frizzled/PCP signaling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet 2007;8:126-138 (Pubitemid 46127401)
12. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948-963
13. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-346 (Pubitemid 35154440)
14. Block TM. Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-5107 (Pubitemid 37059591)
15. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006;6:674-687 (Pubitemid 44286000)
16. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576 (Pubitemid 46890874)
17. Fukutomi T, Zhou Y, Kawai S, et al. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of Wnt-1 expression. Hepatology 2005;41:1096-1105 (Pubitemid 40593917)
18. Lee TH, Tai DI, Cheng CJ, et al. Enhanced nuclear factor-κB- associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics. J Biomed Sci 2006;13:27-39. (Pubitemid 43162503)
19. Xu XR, Huang J, Xu ZG, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A 2001;98:15089-15094 (Pubitemid 34013974)
20. Papkoff J, Brown AMC, Varmus RE. The int-1 proto-oncogene products are glycoproteins that appear to enter the secretory pathway. Mol Cell Biol 1987;7:3978-3984
21. Cha MY, Kim CM, Park YM, et al. Hepatitis B virus X protein is essential for the activation of Wnt/β-catenin signaling in hepatoma cells. Hepatology 2004;39:1683-1693 (Pubitemid 38702670)
22. Merle P, Kim M, Herrmann M, et al. Oncogenic role of frizzled-7/β- catenin pathway in hepatocellular carcinoma. J Hepatol 2005;43:854-862 (Pubitemid 41414512)
23. Schroeder JA, Adriance MC, McConnell EJ, et al. ErbB-β-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-neu transgenic carcinomas. J Biol Chem 2002;277:22692-22698 (Pubitemid 34967248)
24. Sun CS, Wu KT, Lee HH, et al. Antisense morpholino oligonucleotide assay shows critical involvement for NF-κB activation in the production of Wnt-1 protein by HepG2 cells: oncology implications. J Biomed Sci 2008;15:633-643
25. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236 (Pubitemid 43112690)
26. Bournat JC, Brown AMC, Soler P. Wnt-1 dependent activation of the survival factor NF-κB in PC12 cells. J Neurosci Res 2000;61:21-32. (Pubitemid 30436471)
27. Tzeng CC, Liu HS, Li C, et al. Characterization of two urothelium cancer cell lines derived from a blackfoot disease endemic area in Taiwan. Anticancer Res 1996;16:1797-1804 (Pubitemid 26270686)
28. Ortega P Juan C, Frias C, Hernández S, et al. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability. Clin Cancer Res 2008;14:995-1001.
29. van Ooyen A, Kwee V, Nusse R. The nucleotide sequence of human int-1 mammary oncogene: evolutionary conservation of coding and non-coding sequences. EMBO J 1985;4:2905-2909
30. Tsai SL, Huang GT, Yang PM, et al. Plasma des-γ-carboxyprothrombin in the early stage of hepatocellular carcinoma. Hepatology 1990;11:481-488 (Pubitemid 20120004)
31. Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004;126:1005-1014 (Pubitemid 38451172)
32. Chen CH, Huang GT, Yang PM, et al. Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis. Eur J Cancer 2006;42:2524-2529 (Pubitemid 44442947)
33. Bartlett DL, Carr BI, Marsh JW. Cancer of the liver. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Baltimore: Lippincott Williams & Wilkins; 2005. p. 986-1009.
34. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for HCC. A univariate and multivariate analysis. Cancer 1990;65:1104-1110
35. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of HCC. Gastroenterology 1993;105:488-494 (Pubitemid 23213535)
36. Poon RTP, Fan ST, Ng IOL, et al. Differential risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500-507 (Pubitemid 30640096)
37. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004;303:1483-1487
38. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-811 (Pubitemid 223002751)
39. Jou TS, Stewart DB, Stappert J, et al. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci U S A 1995;92:5067-5071
40. Behrens J, von Kries JP, Kühl M, et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996;382:638-642 (Pubitemid 26268958)
41. Cadigan KM, Liu YI: Wnt signaling: complexity at the surface. J Cell Sci 2006;119:395-402.
42. Morin PI. β-Catenin signaling and cancer. BioEssays 1999;21:1021-1030
43. Inagawa S, Itabashi M, Adachi S, et al. Expression and prognostic role of β-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res 2002;8:450-456 (Pubitemid 34193964)
44. Prange W, Breuhahn K, Fischer F, et al. β-Catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional Wnt-1 target genes. J Pathol 2003;201:250-259 (Pubitemid 37258936)
45. Muzio LL, Pannone G, Staibano S, et al. WNT-1 expression in basal cell carcinoma of head and neck: an immunohistochemical and confocal study with regard to the intracellular distribution of β-catenin. Anticancer Res 2002;22:565-576 (Pubitemid 34475202)
46. Clevers H. Axin and hepatocellular carcinomas. Nat Genet 2000;24:206-208 (Pubitemid 30132183)
47. de La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 1998;95:8847-8851 (Pubitemid 28350577)
48. Huang H, Fujii H, Sankila A, et al. B-Catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 1999;155:1795-1801
49. Hsu HC, Jeng YM, Mao TL, et al. β-Catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 2000;157:763-770 (Pubitemid 32109369)
50. Branda M, Wands JR. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology 2006;43:891-902. (Pubitemid 43724611)
51. Gilbertson RJ. Medulloblastoma: signaling a change in treatment. Lancet Oncol 2004;5:209-218
52. Rhee CS, Sen M, Lu D, et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002;21:6598-6605 (Pubitemid 35177038)